{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:57:47Z","timestamp":1794250667263,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ctim.2020.102452","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:48:08Z","timestamp":1590184088000},"page":"102452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial"],"prefix":"10.1016","volume":"52","author":[{"given":"Mina","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makan","family":"Cheraghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jafarirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Alavinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2020.102452_bib0005","first-page":"577","article-title":"The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis","volume":"61","author":"Cichoz-Lach","year":"2010","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0010","first-page":"1167","article-title":"Evaluation of melatonin hormone and nitric oxide levels in non-alcoholic fatty liver patients in relation to obesity and oxidative stress","volume":"10","author":"Farhan","year":"2018","journal-title":"J Pharm Sci Res."},{"issue":"2","key":"10.1016\/j.ctim.2020.102452_bib0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2019.04.029","article-title":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1\u03b1-HO-1-PGC1\u03b1-mitochondrial signaling","volume":"380","author":"Raffaele","year":"2019","journal-title":"Exp Cell Res."},{"key":"10.1016\/j.ctim.2020.102452_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.ctim.2020.102452_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12986-018-0297-4","article-title":"Green cardamom increases sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial","volume":"15","author":"Daneshi-Maskooni","year":"2018","journal-title":"Nutr Metab (Lond)."},{"issue":"1","key":"10.1016\/j.ctim.2020.102452_bib0030","doi-asserted-by":"crossref","first-page":"e0148115","DOI":"10.1371\/journal.pone.0148115","article-title":"Hepatic macrosteatosis is partially converted to microsteatosis by melatonin supplementation in ob\/ob mice non-alcoholic fatty liver disease","volume":"11","author":"Stacchiotti","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.ctim.2020.102452_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"issue":"7","key":"10.1016\/j.ctim.2020.102452_bib0040","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur J Sport Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0045","first-page":"75","article-title":"Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease-14 months follow up","volume":"65","author":"Celinski","year":"2014","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/nu9040367","article-title":"Dietary sources and bioactivities of melatonin","volume":"9","author":"Meng","year":"2017","journal-title":"Nutrients."},{"key":"10.1016\/j.ctim.2020.102452_bib0055","first-page":"51","article-title":"Design and rationale of a randomized controlled trial of melatonin supplementation in men and women with the metabolic syndrome","volume":"5","author":"Terry","year":"2013","journal-title":"Open Access J Clin Trials."},{"key":"10.1016\/j.ctim.2020.102452_bib0060","first-page":"1915","article-title":"The investigation of melatonin effect on liver antioxidant and oxidant levels in fructose-mediated metabolic syndrome model","volume":"19","author":"Demirtas","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.arr.2018.04.003","article-title":"The multiple functions of melatonin in regenerative medicine","volume":"45","author":"Majidinia","year":"2018","journal-title":"Ageing Res Rev."},{"issue":"15","key":"10.1016\/j.ctim.2020.102452_bib0070","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s00018-016-2185-2","article-title":"Melatonin role preventing steatohepatitis and improving liver transplantation results","volume":"73","author":"Esteban-Zubero","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0075","doi-asserted-by":"crossref","first-page":"E673","DOI":"10.3390\/ijms18040673","article-title":"Effects of melatonin on liver injuries and diseases","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0080","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fphar.2018.01086","article-title":"Promising antineoplastic actions of melatonin","volume":"9","author":"Favero","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0085","first-page":"705","article-title":"The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin","volume":"61","author":"Gonciarz","year":"2010","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-079X.2012.01023.x","article-title":"Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin","volume":"54","author":"Gonciarz","year":"2013","journal-title":"J Pineal Res."},{"issue":"1","key":"10.1016\/j.ctim.2020.102452_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14218\/JCTH.2018.00008","article-title":"Fatty liver disease and gut microbiota: a comprehensive update","volume":"7","author":"Campo","year":"2019","journal-title":"J Clin Transl Hepatol."},{"key":"10.1016\/j.ctim.2020.102452_bib0100","first-page":"24","article-title":"Effects of melatonin supplementation on weight and body fat mass percentage in overweight or obese people","volume":"19","author":"Mohammadi","year":"2015","journal-title":"J Qazvin Univ Med Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cen.12942","article-title":"Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: a randomized placebo-controlled trial","volume":"84","author":"Amstrup","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.ctim.2020.102452_bib0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s10620-005-2720-8","article-title":"Increased orocecal transit time in patients with nonalcoholic fatty liver disease","volume":"50","author":"Soza","year":"2005","journal-title":"Dig Dis Sci."},{"issue":"7538","key":"10.1016\/j.ctim.2020.102452_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.38731.532766.F6","article-title":"Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis","volume":"332","author":"Buscemi","year":"2006","journal-title":"BMJ."},{"key":"10.1016\/j.ctim.2020.102452_bib0120","first-page":"1","article-title":"Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial","volume":"124","author":"Goyal","year":"2014","journal-title":"Diabetol Metab Syndr."},{"issue":"1","key":"10.1016\/j.ctim.2020.102452_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.ctim.2020.102452_bib0130","first-page":"35","article-title":"The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study","volume":"63","author":"Gonciarz","year":"2012","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/2277-9175.204593","article-title":"The effects of melatonin in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"6","author":"Pakravan","year":"2017","journal-title":"Adv Biomed Res."},{"key":"10.1016\/j.ctim.2020.102452_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-079X.2010.00835.x","article-title":"Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome","volume":"50","author":"Kozir\u00f3g","year":"2011","journal-title":"J Pineal Res."},{"key":"10.1016\/j.ctim.2020.102452_bib0145","first-page":"504","article-title":"A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women","volume":"47","author":"Alamdari","year":"2015","journal-title":"Horm Metab Res."},{"key":"10.1016\/j.ctim.2020.102452_bib0150","first-page":"665","article-title":"Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women","volume":"66","author":"Chojnacki","year":"2015","journal-title":"J Physiol Pharmacol."},{"key":"10.1016\/j.ctim.2020.102452_bib0155","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1108\/NFS-01-2019-0018","article-title":"The role of melatonin supplement in metabolic syndrome: a randomized double blind clinical trial","volume":"49","author":"Bahrami","year":"2019","journal-title":"Nutr Food Sci."},{"key":"10.1016\/j.ctim.2020.102452_bib0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.ctim.2020.102452_bib0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.ctim.2020.102452_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1748-1716.2012.02410.x","article-title":"Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?","volume":"205","author":"Nduhirabandi","year":"2012","journal-title":"Acta Physiol (Oxf)."},{"key":"10.1016\/j.ctim.2020.102452_bib0175","doi-asserted-by":"crossref","first-page":"8494107","DOI":"10.1155\/2017\/8494107","article-title":"Melatonin supplementation lowers oxidative stress and regulates adipokines in obese patients on a calorie-restricted diet","volume":"2017","author":"Szewczyk-Golec","year":"2017","journal-title":"Oxid Med Cell Longev."},{"key":"10.1016\/j.ctim.2020.102452_bib0180","doi-asserted-by":"crossref","first-page":"e12524","DOI":"10.1111\/jpi.12524","article-title":"melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high fat diet-fed mice","volume":"65","author":"Yin","year":"2018","journal-title":"J Pineal Res."},{"issue":"4","key":"10.1016\/j.ctim.2020.102452_bib0185","doi-asserted-by":"crossref","first-page":"e12399","DOI":"10.1111\/jpi.12399","article-title":"Melatonin prevents obesity through modulation of gut microbiota in mice","volume":"62","author":"Xu","year":"2017","journal-title":"J Pineal Res."},{"key":"10.1016\/j.ctim.2020.102452_bib0190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.amjmed.2006.02.002","article-title":"Melatonin reduces night blood pressure in patients with nocturnal hypertension","volume":"119","author":"Grossman","year":"2006","journal-title":"Am J Med."},{"key":"10.1016\/j.ctim.2020.102452_bib0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.HYP.0000113293.15186.3b","article-title":"Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension","volume":"43","author":"Scheer","year":"2004","journal-title":"Hypertension."},{"key":"10.1016\/j.ctim.2020.102452_bib0200","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/1440-1681.12942","article-title":"Role of melatonin in blood pressure regulation: an adjunct anti\u2010hypertensive agent","volume":"45","author":"Baker","year":"2018","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"10.1016\/j.ctim.2020.102452_bib0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/endo.141.2.7311","article-title":"Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat","volume":"141","author":"Wolden-Hanson","year":"2000","journal-title":"Endocrinology."},{"key":"10.1016\/j.ctim.2020.102452_bib0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v5.i4.160","article-title":"Melatonin attenuates high fat diet-induced fatty liver disease in rats","volume":"5","author":"Hatzis","year":"2013","journal-title":"World J Hepatol."}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920304258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920304258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:12:36Z","timestamp":1760807556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229920304258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":42,"alternative-id":["S0965229920304258"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102452","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102452"}}